MISSISSAUGA, ON, June 4, 2015 /PRNewswire/ - Cipher
Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) today announced that
Shawn Patrick O'Brien, President and
Chief Executive Officer, will present at the BIO International
Convention in Philadelphia on
Tuesday, June 16, 2015. The
presentation will take place at 11:30 AM
ET in Theater 3 and will be followed by a Q&A
session.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly
growing specialty pharmaceutical dermatology company with a
diversified portfolio of commercial-stage products that is on pace
to achieve its goal of becoming the most customer-centric
dermatology company in North
America. Cipher acquires best-in-class products and/or
potentially transformative compounds that fulfill high unmet
medical needs. Cipher's experienced management team has a proven
track of successfully managing the required clinical development
and regulatory approval processes and marketing products either
directly or through partners.
Cipher has completed six transactions in 2015, including the
acquisition of Innocutis and its seven branded dermatology
products, to build its U.S. commercial presence, expand its
Canadian dermatology franchise and broaden its pipeline. Its
products include a novel version of the acne medication
isotretinoin, which is marketed as Absorica® in the United States and Epuris® in Canada. Cipher is well-capitalized to drive
long-term, sustained earnings growth by leveraging its proven
clinical development capabilities and efficient commercial
execution. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.